The Outlook on the Long-term IDR is Stable. The affected banks are KfW, Landwirtschaftliche Rentenbank (Rentenbank), NRW.BANK, Investitionsbank Berlin ( IBB ), Investitionsbank Schleswig-Holstein (IB.SH) and Landeskreditba
Bank of China [3988.hk], WynnMacau [1128.hk], SJMHoldings [880.hk], Singapore REITs . Short – SOXX, SOCL, IBB , Australian dollar Herro: Cie.FinanciereRichmont [CFR.sw], DEO, TM, BNPParibas [BNP.fr] Shafer: CCOI, NICE
I really like VNQ, should I sell before rates go up? Will XLU be killed? What about IBB ? Probably don't want bonds, or treasuries, like: EDV, TLT, or BOND? Any thoughts?
rose 32.4%. Possibly the most dramatic example of momentum loss is in the biotechnology sector. The iShares NASDAQ Biotechnology ( IBB ), an exchange-traded fund, appreciated 65% in 2013. From the start of 2014 through February, the
the biotechs, including HQH/HQL. The Nasdaq Biotech Index (^NBI) is down 19% from the late February highs, along with IBB , a benchmark ETF, and the CEFs, when the latter are adjusted for distributions. They all seem to have stabilized this week
that for longer-term, go passive for stock funds and active for bond funds. Pg 35: Biotechs are hot and the related ETFs [ IBB , XBI ] are attracting huge inflows [YTD inflows are already more than those for entire 2013]. The P/E of XBI is 33 excluding
including Epizyme, Agios Pharmaceuticals and Chimerix. Because the index serves as the basis for the iShares Nasdaq Biotechnology Index Fund, which is an exchange traded fund (ETF), any company added to it automatically gains access
Pacific (Emerging) ETFs, Financials, and two Small Cap ETFs came up also but the big category turned out to be HealthCare. IBB at 12.23%, BBH up 11.71% and XBI up 12.21% to name a few. I counted 12 ETFs up over 6% in the 1 Mon (%). I'm
time, and on this Thanksgiving Day, I give thanks to Rajiv Kaul, the smart PM who runs it. I continue to have a high level of confidence in Kaul and this sector fund. I also own IBB , but prefer smart active management when I can find it.
Alerian MLP AMLP 1.7% iShares Core S&P Small-Cap IJR 6.2% Vanguard Total Bnd Mkt BND 1.0% iShares Nasdaq Biotech IBB 8.2% Vanguard Extended Mkt Index VXF 6.0% Vanguard Info Tech VGT 3.9% Source: Morningstar, Data as of Sept. 30